The U.S. Food and Drug Administration on Wednesday warned about the risk of a rare but serious allergic reaction with the use ...
The U.S. Food and Drug Administration on Wednesday warned about the risk of a rare but serious allergic reaction with the use ...
Findings show accumulation of neuronal injury and functional decline suggesting that changes in gonadal hormones may be associated with changes in functional and biological markers in MS.
A promising new treatment accelerates myelin repair, potentially restoring vision and improving brain function in people with ...
People with multiple sclerosis (MS) face a significantly higher risk of perinatal mental illness compared to those with other ...
The FDA issued a boxed warning for anaphylaxis risk linked to Glatiramer acetate and Glatopa, used in MS treatment.
After years of legal wrangling surrounding Teva’s Copaxone, the latest hit to the lucrative multiple sclerosis drug comes in ...
GlobalData on MSN4d
FDA adds boxed warning to multiple sclerosis drugs after anaphylaxis casesTeva Pharmaceutical’s Copaxone was approved by the FDA in 1996 to treat relapsing forms of MS, an autoimmune disorder that ...
A new study reveals that people with multiple sclerosis (MS) experience significantly higher rates of mental illness during ...
A recent study shows that menopause may worsen Multiple Sclerosis symptoms and accelerate its progression due to a decline in ...
Millions of Americans provide unpaid care for their loved ones at home. NPR's Ayesha Rascoe speaks with reporter Kat McGowan ...
Patients should stop taking glatiramer acetate and seek immediate medical attention by going to an emergency room or calling ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback